Skip to Main content Skip to Navigation
Journal articles

Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan.

Abstract : PURPOSE: In patients with advanced colorectal cancer, leucovorin, fluorouracil, and irinotecan (FOLFIRI) is considered as one of the reference first-line treatments. However, only about half of treated patients respond to this regimen, and there is no clinically useful marker that predicts response. A major clinical challenge is to identify the subset of patients who could benefit from this chemotherapy. We aimed to identify a gene expression profile in primary colon cancer tissue that could predict chemotherapy response. PATIENTS AND METHODS: Tumor colon samples from 21 patients with advanced colorectal cancer were analyzed for gene expression profiling using Human Genome GeneChip arrays U133. At the end of the first-line treatment, the best observed response, according to WHO criteria, was used to define the responders and nonresponders. Discriminatory genes were first selected by the significance analysis of microarrays algorithm and the area under the receiver operating characteristic curve. A predictor classifier was then constructed using support vector machines. Finally, leave-one-out cross validation was used to estimate the performance and the accuracy of the output class prediction rule. RESULTS: We determined a set of 14 predictor genes of response to FOLFIRI. Nine of nine responders (100% specificity) and 11 of 12 nonresponders (92% sensitivity) were classified correctly, for an overall accuracy of 95%. CONCLUSION: After validation in an independent cohort of patients, our gene signature could be used as a decision tool to assist oncologists in selecting colorectal cancer patients who could benefit from FOLFIRI chemotherapy, both in the adjuvant and the first-line metastatic setting.
Document type :
Journal articles
Complete list of metadatas

https://www.hal.inserm.fr/inserm-00147002
Contributor : Yves Le Ster <>
Submitted on : Tuesday, May 15, 2007 - 5:06:37 PM
Last modification on : Monday, May 27, 2019 - 1:16:02 PM
Document(s) archivé(s) le : Wednesday, April 7, 2010 - 2:20:06 AM

Identifiers

Collections

Citation

Maguy del Rio, Franck Molina, Caroline Bascoul-Mollevi, Virginie Copois, Frédéric Bibeau, et al.. Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan.. Journal of Clinical Oncology, American Society of Clinical Oncology, 2007, 25 (7), pp.773-80. ⟨10.1200/JCO.2006.07.4187⟩. ⟨inserm-00147002⟩

Share

Metrics

Record views

328

Files downloads

1341